-
公开(公告)号:US11383098B2
公开(公告)日:2022-07-12
申请号:US16516463
申请日:2019-07-19
申请人: Immunolight, LLC , Duke University
发明人: Tuan Vo-Dinh , Jonathan P. Scaffidi , Venkata Gopal Reddy Chada , Benoit Lauly , Yan Zhang , Molly K. Gregas , Ian Nicholas Stanton , Joshua T. Stecher , Michael J. Therien , Frederic A. Bourke, Jr. , Harold Walder , Zak Fathi , Jennifer A. Ayres , Zhenyuan Zhang , Joseph H. Simmons , Stephen John Norton
IPC分类号: A61N5/06 , A61K49/00 , A61N1/40 , A61N5/02 , A61B5/00 , A61B5/055 , A61B6/00 , A61K41/00 , A61M5/00 , A61L2/00 , A61L2/08 , A61N5/067 , A61N5/10
摘要: Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength λ1, to generate a second wavelength λ2 of radiation having a higher energy than the first wavelength λ1. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.
-
公开(公告)号:US10384071B2
公开(公告)日:2019-08-20
申请号:US15247367
申请日:2016-08-25
申请人: IMMUNOLIGHT, LLC. , DUKE UNIVERSITY
发明人: Tuan Vo-Dinh , Jonathan P. Scaffidi , Venkata Gopal Reddy Chada , Benoit Lauly , Yan Zhang , Molly K. Gregas , Ian Nicholas Stanton , Joshua T. Stecher , Michael J. Therien , Frederic A. Bourke, Jr. , Harold Walder , Zak Fathi , Jennifer A. Ayres , Zhenyuan Zhang , Joseph H. Simmons , Stephen John Norton
IPC分类号: A61N5/06 , A61K49/00 , A61N1/40 , A61N5/02 , A61B5/00 , A61B5/055 , A61B6/00 , A61K41/00 , A61M5/00 , A61N5/10 , A61L2/00 , A61L2/08 , A61N5/067
摘要: System for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The system can be used in methods which can be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure.
-
公开(公告)号:US09526913B2
公开(公告)日:2016-12-27
申请号:US14168795
申请日:2014-01-30
申请人: IMMUNOLIGHT, LLC , DUKE UNIVERSITY
发明人: Tuan Vo-Dinh , Jonathan P. Scaffidi , Venkata Gopal Reddy Chada , Benoit Lauly , Yan Zhang , Molly K. Gregas , Ian Nicholas Stanton , Joshua T. Stecher , Michael J. Therien , Frederic A. Bourke, Jr. , Harold Walder , Zak Fathi , Jennifer A. Ayres , Zhenyuan Zhang , Joseph H. Simmons , Stephen John Norton
CPC分类号: A61N5/062 , A61B5/0059 , A61B5/0071 , A61B5/055 , A61B5/4848 , A61B6/481 , A61K41/0042 , A61K41/0052 , A61K41/0061 , A61K49/0039 , A61L2/0047 , A61L2/08 , A61L2202/21 , A61L2202/22 , A61M5/007 , A61N1/406 , A61N5/02 , A61N5/0601 , A61N5/0618 , A61N5/0622 , A61N5/0624 , A61N5/10 , A61N2005/063 , A61N2005/0656 , A61N2005/0659 , A61N2005/0662 , A61N2005/067 , A61N2005/1098
摘要: A nanoparticle-based system for enhancement of emitted light inside a medium. The nanoparticle-based system includes a phosphorescent material which, upon activation, produces the emitted light, and a metallic structure attached to the phosphorescent material. The metallic structure has a surface plasmon resonance which resonates at a frequency which spectrally overlaps with one or more frequencies of the emitted light.
摘要翻译: 一种用于增强介质内发射光的基于纳米颗粒的系统。 基于纳米颗粒的系统包括磷光材料,其在激活时产生发射的光,以及附着到磷光材料的金属结构。 金属结构具有表面等离子体共振,其以与所发射的光的一个或多个频率光谱重叠的频率谐振。
-
4.
公开(公告)号:US11278861B2
公开(公告)日:2022-03-22
申请号:US16900091
申请日:2020-06-12
申请人: IMMUNOLIGHT, LLC , DUKE UNIVERSITY
IPC分类号: B01J19/12 , A23L3/26 , A61L2/00 , C02F1/30 , C02F1/72 , A23L5/30 , B01J19/08 , A61L2/08 , A61L2/10 , A61L2/16 , C08J3/28 , G21K5/00 , C02F1/32 , A61K41/00 , A61N5/06 , A61N5/10 , B01J23/50 , B01J23/52 , B01J31/02 , B01J31/22 , B01J35/00 , B01J37/00 , B01J37/02 , C09D201/00 , C09J5/00 , C09J201/00 , A23L2/50 , A23L3/28 , C08J3/24 , C08J7/18 , G02B5/00 , A61M1/36 , C12H1/06 , B82Y20/00 , B82Y30/00 , B82Y40/00
摘要: A method and a system for producing a change in a medium disposed in an artificial container. The method places in a vicinity of the medium at least one of a plasmonics agent and an energy modulation agent. The method applies an initiation energy through the artificial container to the medium. The initiation energy interacts with the plasmonics agent or the energy modulation agent to directly or indirectly produce the change in the medium. The system includes an initiation energy source configured to apply an initiation energy to the medium to activate the plasmonics agent or the energy modulation agent.
-
公开(公告)号:US09283275B2
公开(公告)日:2016-03-15
申请号:US14573511
申请日:2014-12-17
申请人: Duke University , Immunolight, LLC
CPC分类号: A61K41/0061 , A61K9/14 , A61K9/143 , A61K31/37 , A61K39/00 , A61K41/0028 , A61K41/0066 , A61K47/52 , A61K2039/57 , A61N5/06 , A61N5/062
摘要: The use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell proliferation disorders, and the PEPST and EPEP agents and probes used therein.
-
公开(公告)号:US10300299B2
公开(公告)日:2019-05-28
申请号:US15786046
申请日:2017-10-17
申请人: Immunolight, LLC , Duke University
IPC分类号: A61K41/00 , A61N5/06 , A61K31/7056 , A61K47/55 , A61K31/4427 , A61K31/7052
摘要: The present invention relates to methods for treating cell proliferation disorders comprising: (1) administering to the subject at least one activatable pharmaceutical agent that is capable of activation by a simultaneous two photon absorption event and of effecting a predetermined cellular change when activated; (2) administering at least one plasmonics-active agent to the subject, and (3) applying an initiation energy from an initiation energy source to the subject, wherein the plasmonics-active agent enhances or modifies the applied initiation energy, such that the enhanced or modified initiation energy activates the activatable pharmaceutical agent by the simultaneous two photon absorption event in situ, thus causing the predetermined cellular change to occur, wherein said predetermined cellular change treats the cell proliferation related disorder; and the use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell proliferation disorders, and the PEPST and EPEP agents and probes; a kit and a computer implemented system for performing the method; a pharmaceutical composition useful in the method; and a method for causing an autovaccine effect in a subject using the method.
-
7.
公开(公告)号:US20170173350A1
公开(公告)日:2017-06-22
申请号:US15443656
申请日:2017-02-27
申请人: IMMUNOLIGHT, LLC. , DUKE UNIVERSITY
IPC分类号: A61N5/06 , C08J7/18 , C08J3/28 , C08J3/24 , B01J19/12 , A61L2/10 , A61L2/00 , C02F1/30 , C02F1/32 , C02F1/72 , A23L3/26 , A23L3/28 , A23L2/50 , G21K5/00 , G02B5/00 , A61N5/10 , A61K41/00
CPC分类号: B01J19/123 , A23L2/50 , A23L3/26 , A23L3/263 , A23L3/28 , A23L5/32 , A23V2002/00 , A61K41/0057 , A61K41/0066 , A61L2/0011 , A61L2/0047 , A61L2/0076 , A61L2/082 , A61L2/088 , A61L2/10 , A61L2/16 , A61L2202/21 , A61L2202/22 , A61M1/3683 , A61N5/062 , A61N5/0624 , A61N5/10 , A61N2005/0661 , A61N2005/0662 , A61N2005/1087 , A61N2005/1089 , A61N2005/1098 , B01J19/082 , B01J19/085 , B01J19/12 , B01J19/125 , B01J19/127 , B01J19/128 , B01J23/50 , B01J23/52 , B01J31/0275 , B01J31/2295 , B01J35/0006 , B01J35/0013 , B01J35/004 , B01J37/0072 , B01J37/0221 , B01J2219/0877 , B01J2219/0879 , B01J2219/0892 , B01J2219/1203 , B01J2231/005 , B01J2531/005 , B01J2531/008 , B82Y20/00 , B82Y30/00 , B82Y40/00 , C02F1/30 , C02F1/302 , C02F1/305 , C02F1/307 , C02F1/32 , C02F1/725 , C02F2305/10 , C08J3/24 , C08J3/28 , C08J7/18 , C08J2300/00 , C09D201/00 , C09J5/00 , C09J201/00 , C09J2205/31 , C12H1/06 , G02B5/008 , G21K5/00 , Y02W10/37 , Y10S977/774 , Y10S977/777 , Y10S977/896 , Y10S977/915 , Y10T156/10
摘要: A method and a system for producing a change in a medium disposed in an artificial container. The method places in a vicinity of the medium at least one of a plasmonics agent and an energy modulation agent. The method applies an initiation energy through the artificial container to the medium. The initiation energy interacts with the plasmonics agent or the energy modulation agent to directly or indirectly produce the change in the medium. The system includes an initiation energy source configured to apply an initiation energy to the medium to activate the plasmonics agent or the energy modulation agent.
-
8.
公开(公告)号:US09630022B2
公开(公告)日:2017-04-25
申请号:US14165026
申请日:2014-01-27
申请人: IMMUNOLIGHT, LLC. , DUKE UNIVERSITY
IPC分类号: A61K9/00 , A61K31/00 , A61K33/00 , A61K41/00 , C08F2/50 , C08J3/28 , A61N5/10 , A23L3/26 , A61L2/00 , B01J19/08 , B01J19/12 , C02F1/30 , C02F1/72 , A61L2/08 , A61L2/10 , A61L2/16 , G21K5/00 , C02F1/32 , A61N5/06 , A23L5/30 , B82Y20/00
CPC分类号: A61N5/10 , A23L2/50 , A23L3/26 , A23L3/263 , A23L3/28 , A23L5/32 , A23V2002/00 , A61K41/0057 , A61K41/0066 , A61L2/0011 , A61L2/0047 , A61L2/0076 , A61L2/082 , A61L2/088 , A61L2/10 , A61L2/16 , A61L2202/21 , A61L2202/22 , A61M1/3683 , A61N5/062 , A61N5/0624 , A61N2005/0661 , A61N2005/0662 , A61N2005/1087 , A61N2005/1089 , A61N2005/1098 , B01J19/082 , B01J19/085 , B01J19/12 , B01J19/123 , B01J19/125 , B01J19/127 , B01J19/128 , B01J23/50 , B01J23/52 , B01J31/0275 , B01J31/2295 , B01J35/0006 , B01J35/0013 , B01J35/004 , B01J37/0072 , B01J37/0221 , B01J2219/0877 , B01J2219/0879 , B01J2219/0892 , B01J2219/1203 , B01J2231/005 , B01J2531/005 , B01J2531/008 , B82Y20/00 , B82Y30/00 , B82Y40/00 , C02F1/30 , C02F1/302 , C02F1/305 , C02F1/307 , C02F1/32 , C02F1/725 , C02F2305/10 , C08J3/24 , C08J3/28 , C08J7/18 , C08J2300/00 , C09D201/00 , C09J5/00 , C09J201/00 , C09J2205/31 , C12H1/06 , G02B5/008 , G21K5/00 , Y02W10/37 , Y10S977/774 , Y10S977/777 , Y10S977/896 , Y10S977/915 , Y10T156/10
摘要: A method and a system for producing a change in a medium disposed in an artificial container. The method places in a vicinity of the medium at least one of a plasmonics agent and an energy modulation agent. The method applies an initiation energy through the artificial container to the medium. The initiation energy interacts with the plasmonics agent or the energy modulation agent to directly or indirectly produce the change in the medium. The system includes an initiation energy source configured to apply an initiation energy to the medium to activate the plasmonics agent or the energy modulation agent.
-
公开(公告)号:US11324965B2
公开(公告)日:2022-05-10
申请号:US16511536
申请日:2019-07-15
申请人: IMMUNOLIGHT, LLC. , DUKE UNIVERSITY
发明人: Tuan Vo-Dinh , Jonathan P. Scaffidi , Venkata Gopal Reddy Chada , Benoit Lauly , Yan Zhang , Molly K. Gregas , Ian Nicholas Stanton , Joshua T. Stecher , Michael J. Therien , Frederic A. Bourke, Jr. , Harold Walder , Zak Fathi , Jennifer A. Ayres , Zhenyuan Zhang , Joseph H. Simmons , Stephen John Norton
IPC分类号: A61N5/06 , A61K49/00 , A61N1/40 , A61N5/02 , A61B5/00 , A61B5/055 , A61B6/00 , A61K41/00 , A61M5/00 , A61L2/00 , A61L2/08 , A61N5/067 , A61N5/10
摘要: Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength λ1, to generate a second wavelength λ2 of radiation having a higher energy than the first wavelength λ1. The methods may further be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure. Kits containing products or compositions formulated or configured and systems for use in practicing these methods.
-
10.
公开(公告)号:US10717062B2
公开(公告)日:2020-07-21
申请号:US16238398
申请日:2019-01-02
申请人: IMMUNOLIGHT, LLC , DUKE UNIVERSITY
IPC分类号: B01J19/12 , A23L3/26 , A61L2/00 , C02F1/30 , C02F1/72 , A23L5/30 , B01J19/08 , A61L2/08 , A61L2/10 , A61L2/16 , C08J3/28 , G21K5/00 , C02F1/32 , A61K41/00 , A61N5/06 , A61N5/10 , B01J23/50 , B01J23/52 , B01J31/02 , B01J31/22 , B01J35/00 , B01J37/00 , B01J37/02 , C09D201/00 , C09J5/00 , C09J201/00 , A23L2/50 , A23L3/28 , C08J3/24 , C08J7/18 , G02B5/00 , A61M1/36 , C12H1/06 , B82Y20/00 , B82Y30/00 , B82Y40/00
摘要: A method and a system for producing a change in a medium disposed in an artificial container. The method places in a vicinity of the medium at least one of a plasmonics agent and an energy modulation agent. The method applies an initiation energy through the artificial container to the medium. The initiation energy interacts with the plasmonics agent or the energy modulation agent to directly or indirectly produce the change in the medium. The system includes an initiation energy source configured to apply an initiation energy to the medium to activate the plasmonics agent or the energy modulation agent.
-
-
-
-
-
-
-
-
-